Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 2160.HK
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 0.00 10.55 10.55
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -2.79 9.02 9.28
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 0.00 0.99 0.99
Cash -39.46 0.45 0.75
Capex 0.00 < 0.005 < 0.005
Free Cash Flow 0.00 -0.02 -0.02
Revenue 0.00 0.03 0.03
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 0.00 0.71 0.71
Operating Margin 0.00 -1.40 -1.40
ROA 0.00 -0.06 -0.06
ROE 0.00 -0.06 -0.06
ROIC 1.19 -0.05 -0.05
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 2160.HK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 2160.HK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 2160.HK is permitted for members.